Hematogen Forte and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Hematogen Forte and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: multivitamin with iron
Brand name: Fero-Folic 500, Theragran Hematinic, Ultra Enerforce
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hematogen Forte-Insulin glargine, recombinant Subcutaneous
- Hematogen Forte-Insulin glulisine
- Hematogen Forte-Insulin Glulisine (Cartridges and Pens)
- Hematogen Forte-Insulin Glulisine (Vials)
- Hematogen Forte-Insulin glulisine Subcutaneous
- Hematogen Forte-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Hematogen Softgels
- Insulin glargine and lixisenatide Subcutaneous-Hematron
- Insulin glargine and lixisenatide Subcutaneous-Hemax
- Insulin glargine and lixisenatide Subcutaneous-Heme iron polypeptide
- Insulin glargine and lixisenatide Subcutaneous-HemeNatal OB
- Insulin glargine and lixisenatide Subcutaneous-HemeNatal OB plus DHA